Published October 3, 2026 | Version v1

Rabies in Livestock and Other Domestic Animals: An Updated Review

Description

Rabies is a fatal, progressive viral encephalitis caused by Rabies lyssavirus (family Rhabdoviridae, 
genus Lyssavirus) that affects all warm-blooded animals, including livestock, companion animals and 
wildlife, and remains one of the oldest recognised zoonoses of veterinary and public health importance. 
Although dogs remain the principal reservoir and source of over 99% of human exposures worldwide, 
livestock species-particularly cattle, buffalo, goats, sheep, horses and pigs-are frequently infected through
bites from rabid dogs, wildlife (foxes, jackals, mongoose, skunks and raccoons) and, in Latin America, the 
common vampire bat (Desmodus rotundus), resulting in substantial production and trade losses. This 
review synthesises current knowledge on the aetiology, global and Indian epidemiology, transmission 
dynamics and pathogenesis of rabies in livestock and other animals, with emphasis on species-wise clinical 
presentation across the furious, dumb (paralytic) and, less commonly recognised, atypical/abortive forms. 
Recent field reports (2024-2025), including a point-source rabies cluster in dairy steers in Minnesota, the 
first isolation of rabies virus from a Eurasian badger in Inner Mongolia with implications for wildlife-
livestock spillover, and genetic characterisation of bovine rabies viruses in South Africa, illustrate the 
continuing ecological plasticity of the virus and the risk it poses to production animals even in regions with 
organised control programmes. Advances in laboratory diagnosis, notably the pan-lyssavirus LN34 real-
time RT-PCR assay, are discussed alongside the classical direct fluorescent antibody test. The review 
presents a species-wise classification of clinical signs, differentiates the clinical forms, and consolidates 
current World Health Organization- and World Organisation for Animal Health-aligned recommendations 
on pre- and post-exposure prophylaxis in animals and in humans exposed to rabid or suspect livestock, 
including updated intradermal vaccination regimens. Gaps in surveillance, under-reporting in livestock, 
and the continuing need for mass dog vaccination and One Health coordination to achieve the global 'Zero 
by 30' target are highlighted, along with future research directions including oral wildlife vaccination, 
monoclonal antibody-based biologicals and improved point-of-care diagnostics.

Files

9. BVI SEPTEMBER ISSUE 106-117.pdf

Files (410.7 kB)

Name Size
md5:d72ee4ef5a0c1ce2c39d3ced8e6bdb3e
410.7 kB Preview Download